An AI-powered intervention supported by Google Glass reinforced facial engagement and emotion recognition in a study of children with autism spectrum disorder (ASD), suggesting the digital approach might be a viable way to support those patients without spending five figures on conventional therapy.  

Healthcare company Invistics debuted its newest software March 21—a system that’s more than 90 percent effective in detecting missing drugs from a hospital’s supply.

Smart speakers—devices like the Amazon Echo and Google Home—are reframing the way physicians work in the operating room, allowing for hands-free communication that could cut time and risk, according to research presented at the Society of Interventional Radiology’s 2019 Annual Scientific Meeting in Austin, Texas.

Hacker accessibility and the potential for security breaches weigh heavily on the development of successful AI systems, but a more pressing threat might lie with healthcare regulators like insurance providers and billing companies, the New York Times reported of a Science study March 21.

The Nashville region’s largest health-tech company, Change Healthcare, filed for a $100 million IPO March 15 in preparation for going public, according to the Nashville Business Journal.

A team of researchers in San Francisco have developed an EHR-driven deep learning model that’s able to accurately predict the prognosis of patients with rheumatoid arthritis (RA), according to a study published in JAMA Network Open.

Pittsburgh-based startup SpIntellx has been awarded a $225,000 research grant by the National Science Foundation to further develop its HistoMapr-Breast system—an AI that images whole-slide samples and acts as a computational guide for pathologists.

Anthem Blue Cross is collaborating with Stanford to launch the AI for Health Affiliation program, a corporate affiliates program within the Stanford Department of Computer Sciences that will fund research on how AI can improve the efficiency and value of Anthem Blue Cross and its health plans.

Cleveland Clinic this month announced it’s launching a Center for Clinical Artificial Intelligence (CCAI) dedicated to the development and application of AI in medicine.

French pharmaceutical startup Pharnext is leveraging AI and pleiotropy to develop new drug combinations and repurpose existing therapies, Fortune reported March 19.

Radiology patients are confident artificial intelligence will improve healthcare workflow and efficiency, but they’re skeptical of the tech itself and remain unsure of how AI will factor into the patient experience, according to a study published online March 14 in the Journal of the American College of Radiology.

A multitude of recent studies and success stories suggest artificial intelligence is on its way to topping doctors in accurately diagnosing diseases from asthma to breast cancer—seemingly a step in the right direction. But does the hype surrounding AI’s victories eclipse its shortcomings?